Experts call for stepped-up hepatitis battle

July 24, 2014

The world can beat the cancer-causing disease hepatitis if it raises its game, but treatment programmes need to go hand in hand with those tackling the likes of HIV, experts said Thursday.

Viral hepatitis is a group of infectious diseases known by the letters A, B, C, D or E, which attack the liver.

Despite killing close to 1.4 million people every year—with Asia the hardest-hit region—hepatitis has long failed to grab the spotlight.

Ninety percent of deaths are from hepatitis B and C, responsible for two-thirds of the global liver cancer toll.

"It's a no-brainer. The best way to prevent liver cancer or people dying from is to prevent and treat ," said Samuel So, a liver surgeon and professor at Stanford University in California.

"If you do that, you'll save a lot of lives and a lot of healthcare costs," he told reporters in Geneva.

Hepatitis B and C are transmitted from infected mothers to newborn babies, by unsafe injections during medical procedures and drug use, or unsafe sex.

"Finally we're seeing some real momentum building," said Stefan Wiktor, leader of the hepatitis programme at the World Health Organization.

Testing is crucial, given that of the estimated 500 million people with viral hepatitis, many are unaware of their infection.

"We also need to make sure there is prevention in place, that healthcare-associated transmission is reduced, that injecting drug users to the equipment they need to prevent from getting infected," Wiktor told reporters.

Hepatitis C, notably, is undergoing a "therapeutic revolution", Wiktor said, with new medicines offering a cure rate of 95 percent.

"That totally changes the dynamic about how we should approach this," he added.

Hepatitis kills almost as many people a year as HIV/AIDS, and therefore needs a similar degree of international traction, said So.

People affected by HIV are also particularly vulnerable to hepatitis, with up to 10 million worldwide estimated to be infected with both.

Advances in HIV treatment have prolonged the lives of people with that virus, meaning they have more time to develop hepatitis-related , but hepatitis treatment still lags behind.

"The structure we created for HIV treatment is ideal for hepatitis treatment. It's time that we didn't put these diseases into silos," So said.

Explore further: Deaths from viral hepatitis surpasses HIV/AIDS as preventable cause of deaths in Australia

Related Stories

Deaths from viral hepatitis surpasses HIV/AIDS as preventable cause of deaths in Australia

April 17, 2014
The analysis was conducted by Dr Benjamin Cowie and Ms Jennifer MacLachlan from the University of Melbourne and Melbourne Health, and was presented at The International Liver Congress in London earlier this month.

Hepatitis C remains major problem for HIV patients despite antiretroviral therapy

March 17, 2014
A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that the risk of hepatitis C-associated serious liver disease persists in HIV patients otherwise benefitting from ...

Hepatitis C screening for baby boomers

April 29, 2013
If you were born during 1945-1965, talk to your doctor about getting tested for hepatitis C. The word "hepatitis" means swelling of the liver. Hepatitis is most often caused by a virus. In the United States, the most common ...

Hepatitis C kills more Americans than HIV: study

February 23, 2012
More Americans died in 2007 of hepatitis C infection, which causes incurable liver disease, than from the virus that causes AIDS, US health authorities said this week.

Hepatitis C cured in co-infected HIV patients

July 19, 2014
A multicenter team of researchers report that in a phase III clinical trial, a combination drug therapy cures chronic hepatitis C in the majority of patients co-infected with both HIV and hepatitis C.

WHO urges global push to treat hepatitis C (Update)

April 9, 2014
The World Health Organization called Wednesday for a dramatic increase in screening and treatment of hepatitis C, saying higher demand would help drive down the cost of drugs for the disease.

Recommended for you

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.